Inno-Gene Valuation

Is IGN undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

Below Fair Value
Significantly Below Fair Value
Price-To-Book vs Peers
Price-To-Book vs Industry
Price-To-Book vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of IGN when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate IGN's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate IGN's fair value for valuation analysis.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for IGN?

Key metric: As IGN barely has revenue we use its Price-To-Book Ratio for relative valuation analysis.

The above table shows the Price to Book ratio for IGN. This is calculated by dividing IGN's market cap by their current book value.
What is IGN's PB Ratio?
PB Ratio	39.3x
Book	zł2.81m
Market Cap	zł114.18m

IGN key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	301.9x
Enterprise Value/EBITDA	-50.9x
PEG Ratio	n/a

Price to Book Ratio vs Peers

How does IGN's PB Ratio compare to its peers?

The above table shows the PB ratio for IGN vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PB	Estimated Growth	Market Cap
Peer Average	5.5x
NNG NanoGroup	10.2x	n/a	zł66.6m
MDB Medicofarma Biotech	3.2x	n/a	zł27.9m
SLV Selvita	3.1x	15.0%	zł982.0m
RVU Ryvu Therapeutics	5.6x	1.7%	zł1.0b
IGN Inno-Gene	39.3x	n/a	zł110.5m

Price-To-Book vs Peers: IGN is expensive based on its Price-To-Book Ratio (39.3x) compared to the peer average (5.5x).

Price to Book Ratio vs Industry

How does IGN's PB Ratio compare vs other companies in the European Life Sciences Industry?

2 Companies	Price / Book	Estimated Growth	Market Cap

2 Companies		Estimated Growth	Market Cap

No more companies

Price-To-Book vs Industry: IGN is expensive based on its Price-To-Book Ratio (39.3x) compared to the European Life Sciences industry average (3.1x).

Price to Book Ratio vs Fair Ratio

What is IGN's PB Ratio compared to its Fair PB Ratio? This is the expected PB Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

IGN PB Ratio vs Fair Ratio.
Fair Ratio
Current PB Ratio	39.3x
Fair PB Ratio	n/a

Price-To-Book vs Fair Ratio: Insufficient data to calculate IGN's Price-To-Book Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.